F Triebel

495 total citations
11 papers, 435 citations indexed

About

F Triebel is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, F Triebel has authored 11 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 3 papers in Hematology. Recurrent topics in F Triebel's work include CAR-T cell therapy research (5 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (4 papers). F Triebel is often cited by papers focused on CAR-T cell therapy research (5 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (4 papers). F Triebel collaborates with scholars based in France. F Triebel's co-authors include Thierry Hercend, Bertrand Huard, Franck Pagès, Philippe Prigent, Denis Bruniquel, S Jitsukawa, Marie‐Paule Lefranc, Florence Faure, Catherine Gaudin and Eric Angevin and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

F Triebel

11 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Triebel France 8 369 197 55 54 34 11 435
John P. Veluchamy Netherlands 7 309 0.8× 281 1.4× 44 0.8× 59 1.1× 60 1.8× 9 399
Randle Ware United States 10 360 1.0× 68 0.3× 17 0.3× 34 0.6× 26 0.8× 13 433
Niklas Hagberg Sweden 14 407 1.1× 93 0.5× 45 0.8× 80 1.5× 26 0.8× 21 533
Hitoshi Deguchi Japan 4 148 0.4× 60 0.3× 70 1.3× 70 1.3× 61 1.8× 5 328
Philip McCoy United States 5 260 0.7× 194 1.0× 26 0.5× 93 1.7× 82 2.4× 11 383
Ah Kau Ng United States 8 234 0.6× 86 0.4× 159 2.9× 117 2.2× 27 0.8× 12 370
Theo Nicholaou Australia 5 357 1.0× 259 1.3× 23 0.4× 107 2.0× 10 0.3× 6 431
Manfred Smetak Germany 9 465 1.3× 357 1.8× 20 0.4× 56 1.0× 62 1.8× 17 573
Erlend Strønen Norway 5 370 1.0× 339 1.7× 68 1.2× 148 2.7× 25 0.7× 7 463
Behiye Kodal United States 10 454 1.2× 399 2.0× 72 1.3× 55 1.0× 31 0.9× 18 535

Countries citing papers authored by F Triebel

Since Specialization
Citations

This map shows the geographic impact of F Triebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Triebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Triebel more than expected).

Fields of papers citing papers by F Triebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Triebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Triebel. The network helps show where F Triebel may publish in the future.

Co-authorship network of co-authors of F Triebel

This figure shows the co-authorship network connecting the top 25 collaborators of F Triebel. A scholar is included among the top collaborators of F Triebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Triebel. F Triebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Huard, Bertrand, Philippe Prigent, Franck Pagès, Denis Bruniquel, & F Triebel. (1996). T cell major histocompatibility complex class II molecules down‐regulate CD4+ T cell clone responses following LAG‐3 binding. European Journal of Immunology. 26(5). 1180–1186. 120 indexed citations
3.
Gaudin, Catherine, Bernard Escudier, M. J. Lacombe, et al.. (1995). In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.. PubMed. 55(3). 685–90. 49 indexed citations
4.
Angevin, Eric, et al.. (1994). Metastatic renal‐cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon γ: Immunological monitoring. International Journal of Cancer. 57(6). 814–821. 6 indexed citations
5.
Dietrich, PY, Anne Caignard, Apiradee Lim, et al.. (1994). In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood. 84(8). 2815–2820. 11 indexed citations
6.
Farace, Françoise, et al.. (1992). Studies on NK cell purification by negative selection in human peripheral blood. Biotherapy. 5(1). 11–20. 6 indexed citations
7.
Dietrich, PY, Anne Caignard, Anita Diu, et al.. (1992). Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease. Blood. 80(9). 2419–2424. 28 indexed citations
8.
Dietrich, PY, Anne Caignard, Anita Diu, et al.. (1992). Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease. Blood. 80(9). 2419–2424. 2 indexed citations
9.
Baixerás, Elena, Sergio Roman‐Roman, S Jitsukawa, et al.. (1990). Cloning and expression of a Lymphocyte Activation Gene (LAG-1). Molecular Immunology. 27(11). 1091–1102. 14 indexed citations
10.
Triebel, F, et al.. (1988). Evidence for expression of two distinct T cell receptor beta -chain transcripts in a human diphtheria toxoid-specific T cell clone.. The Journal of Immunology. 140(1). 300–304. 25 indexed citations
11.
Triebel, F, et al.. (1988). A unique V-J-C-rearranged gene encodes a gamma protein expressed on the majority of CD3+ T cell receptor-alpha/beta- circulating lymphocytes.. The Journal of Experimental Medicine. 167(2). 694–699. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026